47 results
Page 2 of 3
8-K
EX-99.1
qqw iyatc
26 Feb 15
NewLink Genetics Corporation Provides Operational Update and Reports Fourth Quarter and Year End 2014 Financial Results
12:00am
8-K
EX-99.1
dgq2qe2a
22 Dec 14
NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award
12:00am
8-K
EX-99.1
esmg254o6cua8e354aw
24 Nov 14
Merck and NewLink Genetics Enter into Licensing and Collaboration Agreement for Investigational Ebola Vaccine
12:00am
8-K
EX-99.2
5xe90k2fp
2 Jun 14
NewLink Genetics Presents Algenpantucel-L Clinical Data in Poster Discussion Session at ASCO 2014 Annual Meeting
12:00am
8-K
EX-99.1
ja10 5y314ibhfydd
8 Apr 13
NewLink Genetics Presents Preclinical Data on New IDO Pathway Inhibitor, NLG919, at AACR 2013 Annual Meeting
12:00am
8-K
EX-99.1
wut0zi
3 Oct 12
NewLink Genetics Launches Adaptive Design Phase 2B/3 Clinical Trial of tergenpumatucel-L Immunotherapy in Patients with Non-Small Cell Lung Cancer
12:00am